Cargando…

CRISPR/Cas9-Mediated Allele-Specific Disruption of a Dominant COL6A1 Pathogenic Variant Improves Collagen VI Network in Patient Fibroblasts

Collagen VI-related disorders are the second most common congenital muscular dystrophies for which no treatments are presently available. They are mostly caused by dominant-negative pathogenic variants in the genes encoding α chains of collagen VI, a heteromeric network forming collagen; for example...

Descripción completa

Detalles Bibliográficos
Autores principales:	López-Márquez, Arístides, Morín, Matías, Fernández-Peñalver, Sergio, Badosa, Carmen, Hernández-Delgado, Alejandro, Natera-de Benito, Daniel, Ortez, Carlos, Nascimento, Andrés, Grinberg, Daniel, Balcells, Susanna, Roldán, Mónica, Moreno-Pelayo, Miguel Ángel, Jiménez-Mallebrera, Cecilia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025481/ https://www.ncbi.nlm.nih.gov/pubmed/35457228 http://dx.doi.org/10.3390/ijms23084410

Ejemplares similares

Personalized in vitro Extracellular Matrix Models of Collagen VI-Related Muscular Dystrophies
por: Almici, Enrico, et al.
Publicado: (2022)

The Capillary Morphogenesis Gene 2 Triggers the Intracellular Hallmarks of Collagen VI-Related Muscular Dystrophy
por: Castroflorio, Enrico, et al.
Publicado: (2022)

Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
por: Trifunov, Selena, et al.
Publicado: (2020)

Innovative Computerized Dystrophin Quantification Method Based on Spectral Confocal Microscopy
por: Codina, Anna, et al.
Publicado: (2023)

Proteomic and functional characterisation of extracellular vesicles from collagen VI deficient human fibroblasts reveals a role in cell motility
por: Badosa, Carmen, et al.
Publicado: (2023)

Full-Length SMN Transcript in Extracellular Vesicles as Biomarker in Individuals with Spinal Muscular Atrophy Type 2 Treated with Nusinersen
por: Trifunov, Selena, et al.
Publicado: (2023)

Pathological Features in Paediatric Patients with TK2 Deficiency
por: Jou, Cristina, et al.
Publicado: (2022)

Characterization of three TRAPPC11 variants suggests a critical role for the extreme carboxy terminus of the protein
por: Milev, Miroslav P., et al.
Publicado: (2019)

Publisher Correction: Characterization of three TRAPPC11 variants suggests a critical role for the extreme carboxy terminus of the protein
por: Milev, Miroslav P., et al.
Publicado: (2020)

The Increasing Impact of Translational Research in the Molecular Diagnostics of Neuromuscular Diseases
por: Yubero, Dèlia, et al.
Publicado: (2021)

Gene Expression Profiling Identifies Molecular Pathways Associated with Collagen VI Deficiency and Provides Novel Therapeutic Targets
por: Paco, Sonia, et al.
Publicado: (2013)

Differences in Adipose Tissue and Lean Mass Distribution in Patients with Collagen VI Related Myopathies Are Associated with Disease Severity and Physical Ability
por: Rodríguez, M. A., et al.
Publicado: (2017)

Wnt Pathway Extracellular Components and Their Essential Roles in Bone Homeostasis
por: Martínez-Gil, Núria, et al.
Publicado: (2022)

Chronic inflammatory demyelinating polyneuropathy associated with contactin-1 antibodies in a child
por: Carrera-García, Laura, et al.
Publicado: (2019)

Correction: Gene Expression Profiling Identifies Molecular Pathways Associated with Collagen VI Deficiency and Provides Novel Therapeutic Targets
por: Paco, Sonia, et al.
Publicado: (2015)

Common pathophysiology for ANXA11 disorders caused by aspartate 40 variants
por: Natera‐de Benito, Daniel, et al.
Publicado: (2023)

ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011)

siRNA-mediated Allele-specific Silencing of a COL6A3 Mutation in a Cellular Model of Dominant Ullrich Muscular Dystrophy
por: Bolduc, Véronique, et al.
Publicado: (2014)

Mitochondrial Dynamics and Mitochondria-Lysosome Contacts in Neurogenetic Diseases
por: Pijuan, Jordi, et al.
Publicado: (2022)

Dominance of Deleterious Alleles Controls the Response to a Population Bottleneck
por: Balick, Daniel J., et al.
Publicado: (2015)

Fine Mapping of Dominant X-Linked Incompatibility Alleles in Drosophila Hybrids
por: Matute, Daniel R., et al.
Publicado: (2014)

Study of the collagen type VI alpha 3 (COL6A3) gene in Parkinson’s disease
por: Jin, Chong-Yao, et al.
Publicado: (2021)

A Schematic Approach to Defining the Prevalence of COL VI Variants in Five Years of Next-Generation Sequencing
por: Marinella, Gemma, et al.
Publicado: (2022)

Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in Dystrophinopathies
por: Alonso-Jiménez, Alicia, et al.
Publicado: (2021)

Allele dependent silencing of COL1A2 using small interfering RNAs
por: Lindahl, Katarina, et al.
Publicado: (2008)

Allelic heterogeneity contributes to variability in ocular dysgenesis, myopathy and brain malformations caused by Col4a1 and Col4a2 mutations
por: Kuo, Debbie S., et al.
Publicado: (2014)

Kidney Disease Associated With Mono-allelic COL4A3 and COL4A4 Variants: A Case Series of 17 Families
por: Groen in ’t Woud, Sander, et al.
Publicado: (2023)

Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies
por: Bovolenta, Matteo, et al.
Publicado: (2010)

Correction: Fine Mapping of Dominant X-Linked Incompatibility Alleles in Drosophila Hybrids
por: Matute, Daniel R., et al.
Publicado: (2015)

Functional biology of the Steel syndrome founder allele and evidence for clan genomics derivation of COL27A1 pathogenic alleles worldwide
por: Gonzaga-Jauregui, Claudia, et al.
Publicado: (2020)

Five new cases of syndromic intellectual disability due to KAT6A mutations: widening the molecular and clinical spectrum
por: Urreizti, Roser, et al.
Publicado: (2020)

New COL6A6 Variant Causes Autosomal Dominant Retinitis Pigmentosa in a Four-Generation Family
por: Vaclavik, Veronika, et al.
Publicado: (2022)

Should We Diagnose Autosomal Dominant Alport Syndrome When There Is a Pathogenic Heterozygous COL4A3 or COL4A4 Variant?
por: Savige, Judy
Publicado: (2018)

Autosomal dominant mutation in COL7A1 gene causing epidermolysis bullosa dystrophica
por: Sheth, Jayesh, et al.
Publicado: (2014)

Inference of population structure using multilocus genotype data: dominant markers and null alleles
por: FALUSH, DANIEL, et al.
Publicado: (2007)

Genotype-Phenotype Correlations for Pathogenic COL4A3–COL4A5 Variants in X-Linked, Autosomal Recessive, and Autosomal Dominant Alport Syndrome
por: Savige, Judy, et al.
Publicado: (2022)

Flow cytometry analysis: A quantitative method for collagen VI deficiency screening
por: Kim, J., et al.
Publicado: (2012)

Allelic expression analysis of the osteoarthritis susceptibility gene COL11A1 in human joint tissues
por: Raine, Emma V A, et al.
Publicado: (2013)

Bovine Polledness – An Autosomal Dominant Trait with Allelic Heterogeneity
por: Medugorac, Ivica, et al.
Publicado: (2012)

The Selective Maintenance of Allelic Variation Under Generalized Dominance
por: Spencer, Hamish G., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3ht94cs6326v4l1t71518ebv7d